harbinger-health.comHealthcare / BioTech & PharmaFounded: 2018Funding to Date: $540.38MM
Harbinger Health is a biotechnology company focused on detecting early cancer and enabling foundationally new approaches to cancer screening, diagnosis and management that combines advances in artificial intelligence with proprietary insights into the biology of the beginnings of cancer to identify cancer before it is visible or symptomatic with the aim of developing a low-cost, multi-cancer blood test.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
09/28/2023 | Series B | $140MM | $xx.xx | $692.58MM | Catalyst, Flagship Pioneering, M&G Investments, Modi Ventures, Partners Investment, Pictet | |
Price per Share
$xx.xx
Shares Outstanding
15,217,391
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
6.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Catalyst, Flagship Pioneering, M&G Investments, Modi Ventures, Partners Investment, Pictet
|
||||||
12/07/2021 | Series A | $13.04MM | $xx.xx | $132.92MM | Flagship Pioneering | |
Price per Share
$xx.xx
Shares Outstanding
13,041,916
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Flagship Pioneering
|
||||||
12/07/2021 | Series A-1 | $27.09MM | $xx.xx | $132.92MM | Flagship Pioneering | |
Price per Share
$xx.xx
Shares Outstanding
13,542,792
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Flagship Pioneering
|